The global nasopharyngeal cancer treatment market is witnessing significant growth as advancements in oncology therapeutics continue to improve patient outcomes. Nasopharyngeal cancer, a relatively rare malignancy originating in the nasopharynx, has a higher prevalence in certain regions, particularly across Asia-Pacific. Growing awareness regarding early diagnosis, increasing healthcare...